leisure time -WSS

leisure time

author：entertainment 2025-09-30 00:04:59 - browse：231

Multiple syringes in a vial -- Pharma coverage from STAT — Adobe

Roughly two million Americans are expected to receive a cancer diagnosis this year. Some members of this already vulnerable group will wind up facing what physician Andrew Schuman recently called “a tragedy happening in slow motion” — an ongoing, nationwide shortage of critical oncology drugs that routinely save or extend the lives of children and adults.

Speaking at a March 22 Senate hearing on drug shortages, Schuman, a head and neck surgeon at the U.S. Department of Veterans Affairs, described the agonizing decisions that doctors must make when critical medicines are in short supply. “Should our limited vials go to an older woman who was just diagnosed with lung cancer? To a young man who had already been successfully taking it for his testicular cancer? Or a baby with neuroblastoma?” he asked. “As a doctor who has devoted my life to fighting cancer, it is hard to express how horrible it is to face this kind of tragedy.”

The dilemmas caused by cancer drug shortages are unfortunately nothing new. In the past decade alone, eight of the 10 drugs most commonly used to treat acute lymphoblastic leukemia, the most common kind of childhood cancer type of leukemia, have been temporarily unavailable. The problem has been getting worse: Nationwide shortages of critical drugs increased nearly 30% in 2022, soaring to their highest level in nearly five years, according to a report released by the Senate Homeland Security and Governmental Affairs Committee for the hearing. Oncology drugs currently in short supply include methotrexate, which treats breast and soft tissue cancers; cisplatin, which treats testicular, ovarian, bladder, head and neck, lung, and cervical cancers; fluorouracil, which treats skin cancer; Pluvicto, for prostate cancer; and the injectable bacillus Calmette-Guérin, for bladder cancer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： CMS got Medicare Advantage quality rating wrong, judge rules

explore

WSS

My yearlong odyssey to get my son’s ADHD medication covered

Senators tussle over abortion against the backdrop of a presidential campaign

Eli Lilly’s Zepbound improved liver scarring in mid

Finland to offer bird flu vaccine to select groups of people, a possible global first

Biotech venture capitalists face new demands from investors

For pregnant people, addiction treatment shouldn't mean a call to child protective services

hotspot

leisure time

explore

Continuity nursing helped my family in our darkest PICU moments

Dewpoint Therapeutics lays off staff after losing partnerships

DIEP, the 'gold standard' of breast reconstruction, is under threat

An outdated Medicare rule harms dementia patients with anxiety

Medical records are filled with copy

Data don't support strong claims for Covid

Drug repurposing or repositioning? The language matters

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Medicare details structure of new drug price negotiation program

ASCO Daily Recap: CAR

knowledge

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Prior authorization will have to move faster under new Biden rule

Eli Lilly, Pfizer, and others want in on the online prescription market

NIH director takes cautious approach to Biden drug pricing priority

Biotech venture capitalists face new demands from investors

CMS got Medicare Advantage quality rating wrong, judge rules

entertainment

focus

explore

leisure time